Compare FMC Corp (FMC) vs Royal Bank of Canada (RY) Price & Performance
Price performance (Past 24H)
Key statistics
Key statistics
FMC Corp vs Royal Bank of Canada — how do they compare? FMC Corp trades at $11.29 (market cap $1.36B), while Royal Bank of Canada trades at $216 (market cap $299.27B). The key difference: Royal Bank of Canada is far larger — about 220.1× FMC Corp's market cap, and FMC Corp pays the higher dividend (2.95%). Which is the better fit depends on your goals.
| FMC | RY | |
|---|---|---|
Market Cap | $1.36B | $299.27B |
Sector | Basic Materials | Financials |
52-Week High | $43.90 | $217.87 |
52-Week Low | $10.72 | $128.46 |
Enterprise Value | $5.50B | — |
Dividend Yield | 2.95% | 2.34% |
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
Aura AI Summary
Signals from Pluang's Aura AI — not financial advice
FMC Corporation (FMC) trades at $11.61, up 8.3% today, but remains in a challenging fundamental position with a net income margin of -72.93% and negative ROE of -80.78% for 2025. The company is actively restructuring, securing a $400 million minority investment from Tessenderlo Group and planning a $114 million property sale to reduce its $3.03 billion long-term debt. Technical indicators are bearish, with the stock trading near key support at $11. Recent news highlights progress on its new herbicide, rimisoxafen, including a regulatory submission to the EPA and a partnership with Corteva.
The outlook is cautious. While aggressive debt reduction and new product pipelines offer potential, deep losses and declining revenue pose significant risks. The analyst consensus is mixed (47.6% Buy, 50% Hold) with a $16 price target, suggesting modest upside if turnaround efforts succeed, but high execution risk remains the primary concern for investors.
Royal Bank of Canada (RY) trades at $216.98, up 1.37% with bullish technical indicators and strong support at $216. The company shows robust fundamentals with Q1 2026 EPS beating estimates at $2.84, revenue growth to $66.53B in 2025, and a net income margin of 31.85%. Recent shareholder-friendly actions include a dividend increase to $1.76 and a share repurchase program.
RY presents a favorable outlook with consistent earnings beats and solid profitability, though valuation metrics like P/E of 20.11 suggest premium pricing. Risks include economic sensitivity and rising debt levels. Analyst consensus is mixed with 43% buy ratings, indicating cautious optimism for continued performance.
Returns comparison
Trailing returns across standard periods
Returns comparison
Trailing returns across standard periods
About FMC Corp
FMC is a pure-play crop chemical company. The company has diversified its sales to create a balanced crop chemical portfolio across geographies and crop exposure. Through acquisitions, FMC is now one of the five largest patented crop chemical companies and will continue to develop new products, with a focus on biologicals, through its research and development pipeline.
Read more on FMC →About Royal Bank of Canada
Royal Bank of Canada is one of the two largest banks in Canada. It is a diversified financial services company, offering personal and commercial banking, wealth-management services, insurance, corporate banking, and capital markets services. The bank is concentrated in Canada, with additional operations in the U.S. and other countries.
Read more on RY →
